EIF2C is overexpressed and amplified in head and neck squamous cell carcinoma

ORL

Volumn 72, Issue 6, 2010, Pages 337-343

  Chang, Steven S ^a   Smith, Ian ^a   Glazer, Chad ^a   Hennessey, Patrick ^a   Califano, Joseph A ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b GREATER BALTIMORE MEDICAL CENTER   (United States)

Author keywords

EIF2C2; Head and neck squamous cell carcinoma

Indexed keywords

ARGONAUTE 2 PROTEIN; MESSENGER RNA;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; GENE AMPLIFICATION; GENE OVEREXPRESSION; GENE SILENCING; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MICROARRAY; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH;

CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; EUKARYOTIC INITIATION FACTOR-2; HEAD AND NECK NEOPLASMS; HUMANS; MICROARRAY ANALYSIS; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STATISTICS, NONPARAMETRIC;

EID: 77957297335     PISSN: 03011569     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320597     Document Type: Article

References (15)

1. Horner MJ, Ries LAG, Krapcho M, Neyman N, Aminou R, Howlader N, Altekruse SF, Feuer EJ, Huang L, Mariotto A, Miller BA, Lewis DR, Eisner MP, Stinchcomb DG, Edwards BK: SEER Cancer Statistics Review, 1975-2006. Bethesda, National Cancer Institute, 2009.
2. Jemal A, Thomas A, Murray T, Thun M: Cancer statistics, 2002. CA Cancer J Clin 2002; 52: 23-47. (Pubitemid 34110469)
3. Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP: Trends in incidence and prognosis for head and neck cancer in the United States: A site-specific analysis of the SEER database. Int J Cancer 2005; 114: 806-816.
4. Sparano A, Quesnelle KM, Kumar MS, Wang Y, Sylvester AJ, Feldman M, Sewell DA, Weinstein GS, Brose MS: Genome-wide profiling of oral squamous cell carcinoma by array-based comparative genomic hybridization. Laryngoscope 2006; 116: 735-741. (Pubitemid 44318029)
5. Liu J, Carmell MA, Rivas FV, Marsden CG, Thomson JM, Song JJ, Hammond SM, Joshua- Tor L, Hannon GJ: Argonaute2 is the catalytic engine of mammalian RNAi. Science 2004; 305: 1437-1441. (Pubitemid 39167657)
6. O'Carroll D, Mecklenbrauker I, Das PP, Santana A, Koenig U, Enright AJ, Miska EA, Tarakhovsky A: A Slicer-independent role for Argonaute 2 in hematopoiesis and the microRNA pathway. Genes Dev 2007; 21: 1999-2004. (Pubitemid 47267286)
7. Calin GA, Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857-866.
8. Chomczynski P: A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 1993; 15: 532-534, 536-537. (Pubitemid 23270488)
9. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159. (Pubitemid 17064313)
10. Smith IM, S. KM, Liu C, Chang SS, Begum S, Dhara M, Westra W, Sidransky D, Califano JA: Integrative genomic approach to discovery of genes associated with HNSCC development. Arch Otolaryngol, in press.
11. Lee RC, Feinbaum RL, Ambros V: The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993; 75: 843-854. (Pubitemid 24014542)
12. Scaria V, Hariharan M, Pillai B, Maiti S, Brahmachari SK: Host-virus genome interactions: Macro roles for microRNAs. Cell Microbiol 2007; 9: 2784-2794. (Pubitemid 350066564)
13. Lewis BP, Burge CB, Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120: 15-20.
14. Croce CM, Calin GA: MiRNAs, cancer, and stem cell division. Cell 2005; 122: 6-7. (Pubitemid 40977933)
15. Zhang L, Huang J, Yang N, Greshock J, Megraw MS, Giannakakis A, Liang S, Naylor TL, Barchetti A, Ward MR, Yao G, Medina A, O'Brien-Jenkins A, Katsaros D, Hatzigeorgiou A, Gimotty PA, Weber BL, Coukos G: MicroRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci USA 2006; 103: 9136-9141. (Pubitemid 43902545)